NECFA
TMO icon

New England Capital Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

New England Capital Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.57K Hold
11
– – ﹤0.01% 312
2026
Q1 		$5.45K Hold
11
– – ﹤0.01% 304
2025
Q4 		$6.42K Hold
11
– – ﹤0.01% 299
2025
Q3 		$5.37K Hold
11
– – ﹤0.01% 305
2025
Q2 		$4.49K Hold
11
– – ﹤0.01% 312
2025
Q1 		$5.5K Hold
11
– – ﹤0.01% 271
2024
Q4 		$5.75K Hold
11
– – ﹤0.01% 268
2024
Q3 		$6.83K Hold
11
– – ﹤0.01% 249
2024
Q2 		$6.1K Hold
11
– – ﹤0.01% 255
2024
Q1 		$6.41K Hold
11
– – ﹤0.01% 253
2023
Q4 		$5.85K Hold
11
– – ﹤0.01% 266
2023
Q3 		$5.57K Hold
11
– – ﹤0.01% 262
2023
Q2 		$5.74K Buy
+11
New +$5.94K ﹤0.01% 257

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

New England Capital Financial Advisors's TMO Position: Q2 2026 in Review

New England Capital Financial Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 11 shares worth $5.57K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

New England Capital Financial Advisors first reported a position in TMO in Q2 2023 and has held it in 13 quarters since. The position peaked at $6.83K in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • New England Capital Financial Advisors held 11 shares of Thermo Fisher Scientific worth $5.57K as of Q2 2026.
  • New England Capital Financial Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #312 holding.
  • New England Capital Financial Advisors first reported a position in Thermo Fisher Scientific in Q2 2023 and has held it in 13 quarters since.
  • New England Capital Financial Advisors's Thermo Fisher Scientific position peaked at $6.83K in Q3 2024.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.